Fusion Pharmaceuticals Inc. Quarterly Return On Assets in % from Q1 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Return On Assets for the quarter ending March 31, 2024 was -36.9 %, a 4.58% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Return On Assets for 2023 was -35.3 %, a 7.05% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Return On Assets for 2022 was -38 %, a 29% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -36.9 +1.77 +4.58% Jan 1, 2024 Mar 31, 2024
Q4 2023 -35.3 +2.68 +7.05% Oct 1, 2023 Dec 31, 2023
Q3 2023 -36.3 -2.66 -7.91% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.5 -8.81 -28.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.6 -6.52 -20.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38 -8.55 -29% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33.6 -6.95 -26.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -30.7 -8.18 -36.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -32.1 -4.57 -16.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.5 Oct 1, 2021 Dec 31, 2021
Q3 2021 -26.7 Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -27.6 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.